跳至主要内容
临床试验/NCT02609633
NCT02609633已完成不适用

Accu-Chek® CONNECT at School (CATS) Pediatric Study

Hoffmann-La Roche26 个研究点 分布在 1 个国家目标入组 196 人开始时间: 2015年12月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
196
试验地点
26
主要终点
Change From Baseline in Diabetes-Related Distress Among Parents/Caregivers According to the Problem Areas in Diabetes (PAID) Child and Teen (C&T) Parent Questionnaire Score at Month 6

研究概览

简要总结

This interventional, 6-month post-marketing study is designed to evaluate the change in diabetes-related distress among parents/caregivers of school-age children and adolescents with type 1 diabetes (T1D) who are receiving multiple daily injections (MDI) therapy. Investigational sites will be assigned using cluster randomization, with approximately 10 to 20 children at each site. In order to maintain a true control group for comparison, the investigational sites will be randomly assigned to the Accu-Chek® CONNECT Diabetes Management System (DMS) or usual care/continued use of current DMS devices.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
7 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Children or adolescents, aged 6 to 18 years
  • Diagnosis of T1D for at least 3 months
  • Currently managed with insulin Multiple Daily Injection (MDI) therapy
  • Attending full-day school schedule in Grade K through 12
  • Able to provide SMBG data minimum of one month prior to study start
  • Currently using a compatible Smartphone with ability to download the Accu-Chek® CONNECT System App accordingly OR ability to utilize Smartphone and Accu-Chek® CONNECT System App as provided for use in study
  • Adolescents (18 years) with diabetes provide written informed consent
  • Children 7 to 17 years to provide age-appropriate child assent
  • Parent/caregiver currently using a compatible Smartphone with ability to receive Short Message Service/Multimedia Messaging Service (SMS/MMS) messages
  • Able to read/write in English and comply with study procedures, including provision of self-monitoring blood glucose (SMBG) data at least 1 month prior to the study

排除标准

  • Current or planned use of continuous subcutaneous insulin infusions during the study period
  • Use of continuous glucose monitoring or a remote data-sharing system/device (i.e. NightScout, DexCom Share, Medtronic Connect) during the study
  • Pregnancy
  • Clinically significant medical condition(s) such as anemia, major organ system disease, infection, psychosis, or cognitive impairment
  • Requirement for chronic steroids, immunomodulatory medication, or chemotherapy in adrenal suppressive doses
  • Visual impairment preventing use of the Accu-Chek® CONNECT system
  • Parent/caregiver is an investigator, general practitioner, practice staff, pharmacist, research assistant, or other staff or relative of those directly involved in the study

研究组 & 干预措施

Interventional: Accu-Chek® CONNECT DMS

Experimental

Participants will receive training on Day 1 with the Accu-Chek® CONNECT DMS and will thereafter perform SMBG for 6 months. Follow-up office visits will be scheduled at Months 3 and 6 to review and discuss SMBG data and modify the T1D regimen as needed.

干预措施: Accu-Chek® CONNECT DMS (Device)

Control: Usual Care - Current Diabetes Management System (DMS)

Active Comparator

Participants will perform self-monitoring of blood glucose (SMBG) for 6 months using the current DMS device. Follow-up office visits will be scheduled at Months 3 and 6 to review and discuss SMBG data and modify the type 1 diabetes (T1D) regimen as needed.

干预措施: DMS (Device)

结局指标

主要结局

Change From Baseline in Diabetes-Related Distress Among Parents/Caregivers According to the Problem Areas in Diabetes (PAID) Child and Teen (C&T) Parent Questionnaire Score at Month 6

时间窗: Baseline, Month 6

The PAID Questionnaire encompassed 26 items. Score for each question ranges from 1-2 = "Not a Problem" to 5-6 = "Big Problem" (Child version) or 1-2 = "Not a Problem" to 5-6 = "Serious Problem" (Teen or Parent versions). The derived total score (26 questions) ranges between 26 and 156, where higher score indicates worsened condition.

次要结局

  • Change From Baseline in Perceived Family Conflict Among School-Age Children With Diabetes and Parent/Caregiver According to Diabetes Family Conflict Scale (DFCS) Parent Questionnaire Score at Months 3 and 6(Baseline, Months 3 and 6)
  • Change From Baseline in Percentage of Blood Glucose (BG) Measurements Among School-Age Children With Diabetes at Months 3 and 6 Within Glucose Target Range(Baseline, Months 3 and 6)
  • Change From Baseline Blood Glucose Variability Among School-Age Children With Diabetes at Months 3 and 6(Baseline, Months 3 and 6)
  • Change From Baseline in Percentage of Hypoglycemic BG Measurements Among School-Age Children With Diabetes at Months 3 and 6(Baseline, Months 3 and 6)
  • Change From Baseline in Diabetes-Related Distress Among Parents/Caregivers According to the PAID C&T Child Questionnaire Score at Month 3(Baseline, Month 3)
  • Change From Baseline in Affect Towards Blood Glucose Monitoring Among School-Age Children With Diabetes and Parent/Caregiver According to Blood Glucose Monitoring Communication (BGMC) Parent Questionnaire Score at Months 3 and 6(Baseline, Months 3 and 6)
  • Change From Baseline in Diabetes-Related Distress Among School-age Children/Adolescents and Adolescents According to the PAID C&T Child Questionnaire Score at Month 3 and 6(Baseline, Months 3 and 6)
  • Change From Baseline in Glycosylated Hemoglobin A1c (HbA1c) Among School-Age Children With Diabetes at Months 3 and 6(Baseline, Months 3 and 6)
  • Percentage of Participants Who Frequently Used Accu-Chek® CONNECT Diabetes Management System According to a Questionnaire About Usability(Month 6)
  • Percentage of Participants With Participants Preference for Accu-Chek® CONNECT Diabetes Management System With Previous Technology/Process(Month 6)
  • Percentage of Participants With Overall Treatment Satisfaction With the Use of Accu-Chek® CONNECT Diabetes Management System According to a Questionnaire(Month 6)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (26)

Loading locations...

相似试验